Comments
Loading...
Bone Biologics (BBLG) Forecast
NewsEarningsBone Biologics (BBLG) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary
Bone Biologics Stock (NASDAQ: BBLG) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bone Biologics (BBLG) stock?
You can purchase shares of Bone Biologics (NASDAQ:BBLG) through any online brokerage.
Who are Bone Biologics (BBLG) competitors?
Other companies in Bone Biologics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Qualigen Therapeutics (NASDAQ:QLGN).
What is the forecast, or price target, for Bone Biologics (BBLG) stock?
Bone Biologics has a consensus price target of $2.25.
What is the current price for Bone Biologics (BBLG)?
The stock price for Bone Biologics (NASDAQ: BBLG) is $0.95 last updated December 23, 2024 at 11:18 AM EST.
Does Bone Biologics (BBLG) pay a dividend?
There are no upcoming dividends for Bone Biologics.
When is Bone Biologics (NASDAQ:BBLG) reporting earnings?
Bone Biologics’s Q4 earnings are confirmed for Wednesday, February 19, 2025.
Is Bone Biologics (BBLG) going to split?
There is no upcoming split for Bone Biologics.
What sector and industry does Bone Biologics (BBLG) operate in?
Bone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.